PathAI logo

AI-based histologic measurement of NASH (AIM-NASH): A drug development tool for assessing clinical trial end points

EASL 2021

Study Background

Limitations of manual pathology may confound results of NASH clinical trials. Our aim was to develop an AI-based drug development tool (AIM-NASH) that reproducibly calculates NASH Clinical Research Network (CRN) scores.
View Abstract


Prakash et al.